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Abstract 
Aim: The paper aims to investigate the use of maximum likelihood estimation 
to infer measurement types with their distribution shape. Material and 
Methods: A series of twenty-eight sets of observed data (different properties 
and activities) were studied. The following analyses were applied in order to 
meet the aim of the research: precision, normality (Chi-square, Kolmogorov-
Smirnov, and Anderson-Darling tests), the presence of outliers (Grubbs’ test), 
estimation of the population parameters (maximum likelihood estimation 
under Laplace, Gauss, and Gauss-Laplace distribution assumptions), and 
analysis of kurtosis (departure of sample kurtosis from the Laplace, Gauss, 
and Gauss-Laplace population kurtosis). Results:  The mean of most 
investigated sets was likely to be Gauss-Laplace while the standard deviation 
of most investigated sets of compound was likely to be Gauss. The MLE 
analysis allowed making assumptions regarding the type of errors in the 
investigated sets. Conclusions: The proposed procedure proved to be useful in 
analyzing the shape of the distribution according to measurement type and 
generated several assumptions regarding their association. 
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Introduction 
 
Experimental data plays an important role in the validity of quantitative Structure-
Activity Relationship (qSAR) models. The precision and accuracy of experimental data 
influence the uncertainty of a qSAR model. The variability in the descriptors values used in 
modeling [1], the correct choice of the variables involved, the factors that influence the 
activity/property [2] also influence the validity of qSAR models. The accuracy refers to how 
experiments are carried out. The two types of errors (gross errors) that may occur can be 
eliminated by checking instruments against the standard, repeating measurements, using 
standard procedures, calibrating devices, etc. These types of errors could be classified as 
instrumental (always limited by the equipment and protocol used) and human (natural human 
biases, as for example reading errors). Experimental accuracy could be related to the existence 
of systemic errors (e.g. differences between laboratories, differences between researchers, 
etc.) [3]. Consequently, the statistical identification of any types of errors in experimental data 
is a relevant issue in qSAR analyses due to its impact on the estimation / prediction model. 
Maximum likelihood (ML) [4] is a method used to find parameters that maximize the 
observation probability. The main properties of the maximum likelihood method are as 
follows [5]: ▪ consistency (the estimated MLE parameter is asymptotically consistent (n→∞)); 
▪ normality (the estimated MLE parameter is asymptotically, normally distributed with 
minimal variance); ▪ invariance (the maximum likelihood solution is invariant when 
parameters change); ▪ efficiency (if efficient estimators exist for a give problem, the 
maximum likelihood method will find them). The method may also be used to evaluate the 
uncertainty of qSAR models [6-9].  
The present research aimed to use the maximum likelihood estimation method in order 
to assess the association between measurement types and the power of error according to error 
type. 
 
 
Material and Method 
 
Sets of Compounds 
Twenty-eight sets of compounds with a different property / activity were investigated. 
The measured property or activity was taken from previously reported research. A summary 
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of the investigated sets of compounds expressed as sample size, set abbreviation, 
activity/property, existence of ties and associated references are presented in Table 1. 
 
Table 1. Investigated sets of compounds 
No. n  Set [ref]  Activity / Property   Ties
1  209 Y209 [10]  Chromatographic retention times  Yes
2  209 RRF [11]  Relative response factor  Yes
3  206 Y206 [12]  Octanol-water partition coefficient (logKow) Yes
4  205 Y205 [13]  Octanol-water partition coefficient (logKow) Yes
5 166  C166  [14]  Thermodynamic  solubility  Yes
6  143 OrgPest [15,16]  Soil sorption coefficients (KOC) Yes
7  126 Anthra [17-23]  Toxicity on HepG2 cells (logIC50) 
c Yes
8  111 MPC [24-27]  Molecular partition coefficient in n-octanol / water system (logP)  Yes
9  105 MDL [28-38]  Brain-blood partition coefficient (logBBP)
  Yes
10 88  Diamino [39,40]  Antibacterial inhibitory activity (-logIC50) 
f Yes
11 87  lnCHF [41]  Concentration high food (ng/g - lnCHF)  Yes
12 69  AAT [42]  Acute aquatic toxicity (-log[LC50]) LC50
a Yes
13 63  DZGALYL [43]  Resistance index (RI) 
d (-log(RI[taxoid]/RI[paclitaxel]))  No 
14 63  IMHH [44]  Brain-blood partition coefficient (logBBP)  Yes
15 57  InHIV [45]  HIV1 inhibition (log(10
6/C50)) C50
b No 
16 58  InACE [46]  ACE inhibition activity (log(1/IC50)) IC50
c Yes
17 57  Clark [47]  Brain-blood partition coefficient (logBBP)  Yes
18 48  BTA [46]  Bitter tasting activity (log(1/T))  Yes
19 47  MASIS-CAII [48]  Carbonic anhydrase II inhibitory activity (KI, nM))  Yes
20 45  MCY [49,50]  Brain-blood partition coefficient (logBBP)  No 
21 43  BKST [51]  Protonation constant (pKa) No 
22 40  CAI [52]  Carbonic anhydrase I inhibitory activity (logIC50, nM)  Yes
23 40  CAII [52]  Carbonic anhydrase II inhibitory activity (logIC50, nM)  Yes
24 40  CAIV [52]  Carbonic anhydrase IV inhibitory activity (logIC50, nM)  Yes
25 39  Nitro [53]  Toxicity (logLD50, LD50
f (mg/kg))  Yes
26 35  MGWTI [54]  Cell growth inhibitory activity (log1/IC50, IC50 
c) Yes
27 29  TTKSS-CAII [55]  Carbonic anhydrase II inhibitory activity (logKc) Yes
28 25  ERBAT [56]  Estrogen receptor binding affinity (logRBA, LBA 
e) Yes
n = sample size; 
Ties = existence of more than one compound with the same value of property/activity 
aLC50 = 50% lethal dose concentration 
bC50 = compound concentration required to achieve 50% protection of MT-4 cells against HIV 
cIC50 = compound concentration required for 50% growth inhibition 
d Inhibitory effect (IC50) to drug sensitive human breast carcinoma (MCF-7S) and multidrug-resistance 
human breast carcinoma (MCF-7R) – in vitro 
e Relative binding affinity to the estrogen receptor vis-à-vis E2
 
Method 
Experimental data were analyzed progressively in order to achieve the aim of the 
research: 
  Precision analysis. A series of statistical parameters were calculated in order to 
characterize the observed data (minimum, maximum, skewness, kurtosis, standard 
deviation, coefficient of variance (CV=s/m), variance-to-mean ratio (also knows as index 
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of dispersion, VMR = s
2/m). Standard deviation is associated with errors in each 
individual measurement. The skewness evaluated the asymmetry of the distribution while 
the kurtosis showed how far away the distribution of data was from the Gaussian shape. 
The following interpretations for skewness were used [57]: -0.5 < skewness < 0.5: 
distribution is approximately normal; -1 < skewness < -0.5 or 0.5 < skewness > 1: 
distribution is moderately skewed; skewness < -1 or skewness > 1: distribution is highly 
skewed. The data were considered normally distributed if the kurtosis was approximately 
zero; a kurtosis value higher than 0 indicated a leptokurtic distribution; a kurtosis value 
below 0 indicated a platikurtic distribution [58]. 
  Distribution analysis. Three hypotheses regarding the distribution of observed data were 
tested (Laplace, Gauss and Gauss-Laplace) using the EasyFit software [59]. The following 
tests were applied: Chi square [60], Kolmogorov Smirnov [61] and Anderson Darling 
[62]. The Anderson-Darling test was applied because it gives more importance to the tails 
compared to the Kolmogorov-Smirnov test. Moreover, Anderson-Darling is sensitive to 
ties [61]. The outliers seem to bring type II errors to the Kolmogorov-Smirnov test (null 
hypothesis is accepted even if not true) and type I errors (null hypothesis is rejected even 
if true) to Anderson-Darling statistics [63]. 
  Grubbs analysis. Grubbs test [64] was applied whenever appropriate in order to adjust the 
obliquity of experimental data (skewness; -0.5 < skewness < 0.5: distribution was 
considered as approximately symmetric). The characteristics of Grubbs test are as follows: 
a)  Grubbs’ statistics: 
G = [max|Yi - m|]/s  Eq(1)
where I = identification number of compound from the data set (1 ≤ i ≤ n); m = sample mean; 
s = sample standard deviation. 
b)  The test is rejected for two-sided hypothesis if:  
2
2 - n ), n 2 /(
2
2 - n ), n 2 /(
t 2 - n
t
n
) 1 - n (
G
α
α
+
>  
Eq(2)
where n = sample size,   = critical value of the t-distribution with (n-2) degree of 
freedom at a significance level of α. 
2
2 - n ), n 2 /( tα
  Error analysis. Maximum likelihood estimation (MLE) was used as statistical method for 
fitting the experimental data of the investigated sets in order to estimate a series of 
parameters of the model. The following formulas were used: 
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where Xi = measured property / activity for compound i (1 ≤ i ≤ n); µ = population mean; σ = 
population standard deviation; p = power of error; Γ - gamma function. 
The GL(x;µ,σ,p) probability density function features two particular cases: when p = 1 
(fixed) it becomes the Laplace (or error) distribution, and when p = 2 (fixed) it becomes the 
Gauss (or normal) distribution. 
The sample mean of each set of compounds was considered the maximum likelihood 
estimation of the population mean; the sample variance was considered the maximum 
likelihood estimator of the population variance. Three cases of hypothetical distributions were 
investigated in this research: Laplace (p = 1), Gauss (p = 2), and Gauss-Laplace (power of 
error to be estimated) [13]. For each distribution, the population statistical parameters were 
calculated (mean and standard deviation; also power of error for Gauss-Laplace). 
The association of measurement type with the power of error (p) according to the type of 
error was also investigated (Laplace (p = 1) as model for relative error and Gauss (p = 2) for 
absolute error). 
  Kurtosis analysis. The kurtosis of the samples was computed for Laplace (p = 1), Gauss (p 
= 2) and Gauss-Laplace (p as resulted from MLE). The following kurtosis formula for the 
investigated distributions was used to analyze the distance between the sample kurtosis 
and the expected population kurtosis: 
() ( )
() p 3
p 1 p 5
) p ( Kurtosis 2 GL Γ
Γ Γ
=  
Eq(5)
The following two particular cases occurred: Laplace (p = 1) with KurtosisGL(1) = 6 and 
Gauss (p = 2) with KurtosisGL(2) = 3. 
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Results and Discussion 
 
Descriptive statistic parameters expressed as mean (m), standard deviation (s), minim 
(min), maxim (max), skewness (skew), kurtosis (kurt), coefficient of variance (CV) and 
variance-to-mean ratio (VMR) for the investigated sets of compounds were calculated and are 
presented in Table 2. 
 
Table 2. Descriptive statistics of investigated property / activity 
Set n  min  max  m  s  skew kurt  VMR  CV  (%) 
Y209 209  0.10  1.05 0.60 0.18 -0.13 2.72  0.054  30 
RRF 209  0.03  2.04 0.77 0.35 0.56 3.67  0.162  46 
Y206 206  4.15  9.60 6.48 0.83 0.25 3.85  0.106  13 
Y205 205  4.15  9.14 6.47 0.80 0.05 3.28  0.099  12 
C166 166  -6.00  3.35 -0.35 1.81 -0.49 3.20  n.a.  n.a. 
OrgPest 143  0.42  5.31 2.52 0.91 0.77 3.68  0.327 36 
Anthra 126  3.45  7.70 4.74 0.78 1.60 5.94  0.127  16 
Anthra-GO 124  3.45  7.05 4.70 0.69 1.36 5.17  0.103  15 
MPC 111  -0.44  4.79 1.90 1.01 -0.03 2.98  0.538  53 
MDL 105  -2.00  1.44 -0.09 0.77 -0.47 2.86  n.a.  n.a. 
Diamino 88  3.10  6.00 4.84 0.52 -0.81 4.18  0.056  11 
Diamino-GO 87  3.51  6.00 4.86 0.49 -0.58 3.56  0.049  10 
lnCHF 87  0.26  5.77 3.22 1.19 -0.23 2.69  0.442  37 
AAT 69  3.04  6.37 4.25 0.76 0.68 2.93  0.136  18 
DZGALYL 63  -0.57  2.28 0.74 0.68 0.34 2.66  n.a.  n.a. 
IMHH 63  -2.15  1.04 -0.16 0.79 -0.61 2.70  n.a.  n.a. 
InHIV 57  3.07  8.62 6.54 1.50 -0.60 2.36  0.345  23 
InACE 58  1.77  5.80 3.05 1.00 1.09 3.62  0.329  33 
Clark 57  -2.15  1.04 -0.14 0.79 -0.68 2.89  n.a.  n.a. 
BTA 48  1.13  3.60 1.98 0.63 0.84 2.91  0.199  32 
MASIS-CAII 47  0.86  2.51 1.75 0.51 -0.25 1.79  0.149  29 
MCY 45  -2.00  1.04 0.00 0.71 -0.95 3.76  n.a.  n.a. 
ERBAT 25  -2.00  2.22 0.38 1.38 -0.47 1.98  n.a.  n.a. 
CAI 40  0.00  2.66 0.85 0.54 1.45 7.60  0.338  63 
CAII 40  -0.70  2.04 0.47 0.52 0.85 6.04  n.a.  n.a. 
CAIV 40  -0.30  2.51 0.74 0.54 0.98 6.49  n.a.  n.a. 
logCAII-GO 38  -0.70  0.95 0.39 0.38 -0.95 3.55 n.a.  n.a. 
logCAIV-GO 38  -0.30  1.45 0.66 0.39 -0.93 3.78  n.a.  n.a. 
Nitro 39  3.38  8.77 6.50 1.37 -0.53 3.07  0.291  21 
MGWTI 35  -2.00  1.74 -0.69 1.25 0.78 2.15  n.a.  n.a. 
logCAI-GO 34  0.30  1.28 0.85 0.25 -0.25 2.78  0.076  30 
TTKSS-CAII 29  4.41  9.39 7.44 1.41 -0.48 2.29  0.267  19 
BKST 43  5.51  10.53 8.46 1.13 -0.49 3.13  0.151  13 
n = sample size; min = minimum; max = maximum; m = sample mean; s = sample standard deviation;  
skew = skewness; kurt = kurtosis; VMR = Variance-To-Mean Ratio; CV = coefficient of variance 
 
Thirteen out of thirty-three sets of compounds had negative values. The dispersion 
index and the variance coefficient could not be analyzed for these sets due to these negative 
values. 
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The analysis of the skewness revealed that 11 sets of compounds had a moderately 
skewed distribution (probability to be observed is between 1% and 5%), in 7 sets the 
distribution was highly skewed (less than 1% probability to be observed) and in 15 sets the 
distribution was approximately symmetric (no rejection of the symmetry at 5% risk being in 
error). The highly skewed sets comprised Soil sorption coefficients (OrgPest), Relative 
response factor (RRF), and some sets which referred to the concentration of compounds 
required for 50% growth inhibition (Anthra, CAI, InACE and Diamino, the Anthra set 
remained highly skewed following Grubbs test). According to this parameter, 15 sets of 
compounds were expected to have approximately symmetric distribution. The analysis of 
kurtosis revealed that 18 sets of compounds were leptokurtic and 15 platykurtic. According 
kurtosis values, the toxicity on HepG2 cells (Anthra) and Carbonic anhydrase inhibitory 
activity CAI, CAII and CAIV sets were expected to have the Laplace distribution (kurtosis > 
5). 
The analysis of variance-to-mean ratio of the investigated sets of compounds concluded 
that the data were under-dispersed (0 < VMR < 1) without exception. The analysis of the 
results obtained by the variation coefficients (as a measure of relative variation) showed a 
great relative variation (CV ≥ 20) of the experimental data in 17 sets and a small variation (10 
≤ CV < 20) in 9 sets. MPC and CAI presented greatest data variation according to the 
variation coefficients (see Table 2). The removal of the outlier whenever identified by Grubbs 
test did not shift the set of compounds between variation classes (see Table 2). 
The analysis of the results obtained following the investigation of the null hypothesis “the 
observed data followed the Laplace distribution” revealed the following (see Table 3): 
  All three applied tests rejected the null hypothesis at a significance level of 5% for 10 sets: 
RRF, OrgPest, Anthra, Anthra-GO, AAT, InHIV, InACE, BTA, CAII, and CAIV. 
  With two exceptions (AAT and IMHH sets), the Anderson-Darling test rejected the null 
hypothesis for the same sets of compounds as the Chi-square test: Y209, RRF, Y206, 
Y205, OrgPest, Anthra, Anthra-GO, MDL, InHIV, InACE, and BTA. 
  With few exceptions, the null hypothesis of Laplace distribution was rejected at different 
significance levels. The exceptions were: DZGALYL, Clark, MCY, BKST, CAI, Nitro, 
logCAI-GO, ERBAT. 
The Chi-square test rejected the null hypothesis of normality at a significance level of 5% 
in 5 (RRF, Anthra, Anthra-GO, InACE, and BTA) out of 28 cases (see Table 3). The 
87 Observation vs. Observable: Maximum Likelihood Estimations according to the Assumption of Generalized 
Gauss and Laplace Distributions 
Lorentz JÄNTSCHI and Sorana D. BOLBOACĂ  
 
normality has also been rejected by the Kolmogorov-Smirnov and Anderson-Darling tests for 
the Anthra and Anthra-GO sets. These two sets of compounds were the ones in which all 
three normality tests agreed at a 5% significance level. Thus, it can be concluded that the 
toxicity on HepG2 cells did not respect the normal distribution. Note that the adjustment of 
the obliquity of experimental data (Grubbs test) from the Anthra set did not lead to a normal 
distributed data-set. This observation was also true for different significance levels for 
logCAII-GO and logCAIV-GO, which led to the conclusion that there were errors in the 
experimental data (unreliable data). 
 
Table 3. Results of Laplace distribution testing: Chi square (CS), Kolmogorov Smirnov (KS) 
and Anderson Darling (AD) tests 
Chi-square Kolmogorov-Smirnov  Anderson-Darling  Set 
Stat. df p  Reject5% Rejectα% Stat. p  Reject5% Rejectα% Stat. Reject5% Rejectα%
Y209 19.49  7  0.0068  Yes  ≥0.01 0.08769 0.0756  No  ≥0.1 2.7752  Yes ≥0.05 
RRF 28.99  7  1.44·10
-4 Yes  ≥0.01 0.1121  0.0096  Yes  ≥0.02 3.2920  Yes  ≥0.02 
Y206 21.97  7  0.0026  Yes  ≥0.01 0.0844  0.1000  No  0.2  2.7284  Yes  ≥0.05 
Y205 25.19  7  7.03·10
-4 Yes  ≥0.01 0.0920  0.0583  No  ≥0.1 3.1799  Yes ≥0.05 
C166 11.13  7  0.1331  No  0.2  0.0996  0.0692  No  ≥0.1 2.0107  No  ≥0.1 
OrgPest 24.76  7  8.36·10
-4 Yes  ≥0.01 0.1299  0.0145  Yes  ≥0.02 2.566  Yes  ≥0.05 
Anthra 35.32  6  3.74·10
-6 Yes  ≥0.01 0.1784  5.56E-4 Yes  ≥0.01 5.0544  Yes  ≥0.01 
Anthra-GO 35.32  6  3.74·10
-6 Yes  ≥0.01 0.1610  0.0028  Yes  ≥0.01 3.8716  Yes  ≥0.01 
MPC  10.57  6  0.1026  No 0.2 0.1002  0.2011  No n.a. 1.5632  No 0.2 
MDL 19.49  7  0.0068  Yes  ≥0.01 0.0877  .0756 No  ≥0.10 2.7752  Yes  ≥0.05 
Diamino  7.61 6 0.2682  No  n.a.  0.1595 0.0202 Yes  ≥0.05 2.040  No  ≥0.10 
Diamino-GO  9.52 6 0.1460  No  0.2  0.1518 0.0324 Yes  ≥0.05 1.8791  No  0.2 
lnCHF  9.17 6 0.1645  No  0.2  0.1086 0.2388 No  n.a.  1.5085  No  0.2 
AAT 10.69  4  0.0303  Yes  ≥0.05 0.1711  0.0309  Yes  ≥0.05 2.0787  No  ≥0.10 
DZGALYL 3.83 5 0.5738  No  n.a.  0.1139 0.3598 No  n.a.  0.9349  No  n.a. 
IMHH 11.28  4  0.0236  Yes  ≥0.05 0.1316  0.2063  No  n.a.  1.8420  No  0.2 
InHIV 13.09  4  0.0108  Yes  ≥0.02 0.1870  0.0322  Yes  ≥0.05 2.8312  Yes  ≥0.05 
InACE 14.26  5  0.0140  Yes  ≥0.02 0.2011  0.0157  Yes  ≥0.02 2.6301  Yes  ≥0.05 
Clark 7.79  4  0.0996  No  ≥0.10 0.1306  0.2614  No  n.a.  1.5585  No  0.2 
BTA 12.64  3  0.0055  Yes  ≥0.01 0.2518  0.0036  Yes  ≥0.01 2.6130  Yes  ≥0.05 
MASIS-CAII 8.46  4  0.0761  No  ≥0.10 0.14928 0.2224  No  n.a.  2.0537  No  ≥0.10 
MCY  1.39  4  0.8458  No n.a. 0.14979 0.2398  No n.a. 1.1642  No n.a. 
BKST  4.01 4 0.4050  No  n.a.  0.1100 0.6351 No  n.a.  0.6320  No  n.a. 
CAI  2.77 4 0.5967  No  n.a.  0.1110 0.6667 No  n.a.  0.6642  No  n.a. 
CAII 15.34  3  0.0016  Yes  ≥0.01 0.221 0.0658  No  ≥0.10 2.6033  Yes  ≥0.05 
CAIV 15.34  3  0.0016  Yes  ≥0.01 0.2021  0.0658  No  ≥0.10 2.6033  Yes  ≥0.05 
Nitro  3.26 3 0.3527  No  n.a.  0.1573 0.2611 No  n.a.  0.9967  No  n.a. 
logCAII-GO 6.67 3 0.0833  No  ≥0.10 0.2667  0.0071  Yes  ≥0.01 1.9159  No  0.2 
logCAIV-GO  7.28 4 0.1216  No  0.2  0.2288 0.0313 Yes  ≥0.05 1.515  No  0.2 
MGWTI  6.07 3 0.1085  No  0.2  0.2556 0.0167 Yes  ≥0.02 2.8245  Yes  ≥0.05 
logCAI-GO  0.43 4 0.9796  No  n.a.  0.1322 0.5477 No  n.a.  0.5747  No  n.a. 
TTKSS-CAII  5.47 3 0.1402  No  0.2  0.1698 0.3344 No  n.a.  1.1505  No  n.a. 
ERBAT  1.45 2 0.4831  No  n.a.  0.1519 0.5601 No  n.a.  1.1865  No  n.a. 
Stat. = value of the statistics; df = degree of freedom;  
Reject5% = reject the hypothesis at a significance level of 5%;  
Rejectα% = the significance level at which the hypothesis is rejected, whenever appropriate; 
p = p-value; n.a. = not applicable 
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The hypothesis of normality was rejected at different significance levels by the Chi-square 
test in 14 cases (α = 0.2: Y206, MPC, AAT, InHIV, MASIS-CAII, CAI, logCAII-GO; α ≥ 
0.10: CAII; α ≥ 0.01: BTA, Anthra, Anthra-GO; α ≥ 0.01: RRF; α ≥ 0.05: IMHH, Clark). An 
agreement between the applied normality tests (different significance levels, see Table 4) was 
observed for the RRF and BTA sets. 
The Kolmogorov-Smirnov test rejected the hypothesis of normality at a 5% 
significance level in four sets: Anthra, Anthra-GO, MCY and logCAII-GO. Note that the 
hypothesis of normality was only rejected by the Kolmogorov-Smirnov test for the MCY and 
logCAII-GO sets. 
Anderson-Darling, a less conservative normality test, rejected the hypothesis of 
normality at a 5% significance level in only 2 cases (Anthra and Anthra-GO sets, see Table 
4). 
The normality analysis showed that the following sets of compounds were not 
expected to present  the shortest distance between the population (modelled through MLE) 
and the sample mean and between the population and sample standard deviation according to 
the Gauss assumption (p = 2): RRF, Anthra, Anthra-GO, Clark, BTA, MCY, and logCAII-
GO. 
The analysis of the results obtained following the investigation of the null hypothesis 
“the observed data followed the Gauss-Laplace distribution” revealed the following (see 
Table 5): 
  The null hypothesis of Gauss-Laplace distribution was rejected at a 5% significance level 
in all three tests for the Anthra and Anthra-GO sets. 
    The null hypothesis of Gauss-Laplace distribution was rejected at different 
significance levels in all three tests for the RRF and logCAII-GO sets. 
As far as the distribution analysis is concerned, the following conclusions could be 
drawn: 
  The null hypotheses of investigated distributions were rejected by at least two out of three 
applied tests at different significance levels in the following sets: RRF, Anthra, Anthra-
GO, Clark, BTA, CAII, logCAIV-GO, and MGWTI. 
  The following data sets proved to be normally distributed: Y209, Y205, C166, MDL, 
Diamino-GO, lnCHF, DZGALYL, BKST, CAIV, Nitro, logCAI-GO, TTKSS-CAII, and 
ERBAT. A MLR analysis should be applied to these sets. 
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  The Gauss-Laplace distribution proved to be less frequently rejected than the Gauss or 
Laplace distributions. 
 
Table 4. Results of Gauss distribution testing: Chi square (CS), Kolmogorov Smirnov (KS) 
and Anderson Darling (AD) tests 
Chi-square Kolmogorov-Smirnov  Anderson-Darling  Set 
Stat. df p  Reject5% Rejectα% Stat. p  Reject5% Rejectα% Stat. Reject5% Rejectα%
Y209  1.92  7  0.9641  No n.a. 0.0314 0.9823  No n.a. 0.1423  No n.a. 
RRF 17.15  7  0.0165  Yes  ≥ 0.02  0.0857 0.0873  No  ≥ 0.10  1.545  No  0.20 
Y206  11.00  7  0.1386  No 0.20  0.0335 0.9691  No n.a. 0.4443  No n.a. 
Y205  8.64  7  0.2793  No n.a. 0.0358 0.9469  No n.a. 0.3788  No n.a. 
C166  2.99  7  0.8862  No n.a. 0.0551 0.6743  No n.a. 0.5654  No n.a. 
OrgPest 8.06  7  0.3273  No n.a. 0.0849 0.2400  No n.a. 1.7042  No 0.20 
Anthra 24.80  5  1.52·10
-4 Yes  ≥ 0.01  0.1755 7.24·10
-4 Yes  ≥ 0.01  5.6393  Yes  ≥ 0.01 
Anthra-GO 20.16  6  0.0026  Yes  ≥ 0.01  0.1500 0.0067  Yes  ≥ 0.01  4.3883  Yes  ≥ 0.01 
MPC  8.70  6  0.1914  No 0.20  0.0493 0.9378  No n.a. 0.2463  No n.a. 
MDL  6.76  6  0.3438  No n.a. 0.1033 0.1987  No n.a. 1.0269  No n.a. 
Diamino 8.54  6  0.2008  No n.a. 0.1121 0.2029  No n.a. 1.4863  No 0.20 
Diamino-GO  7.31  6  0.2936  No n.a. 0.1079 0.2447  No n.a. 1.2040  No n.a. 
lnCHF  2.17  6  0.9032  No n.a. 0.0599 0.8954  No n.a. 0.3052  No n.a. 
AAT  8.05  5  0.1535  No 0.20  0.1093 0.3557  No n.a. 0.9161  No n.a. 
DZGALYL  4.37  5  0.4978  No n.a. 0.0733 0.8626  No n.a. 0.3885  No n.a. 
IMHH 11.39  4  0.0225  No  ≥  0.05  0.1398 0.1551  No 0.20  1.1324  No n.a. 
InHIV  7.59  4  0.1080  No 0.20  0.1472 0.1528  No 0.20  1.2268  No n.a. 
InACE  2.75  5  0.7384  No n.a. 0.1393 0.1915  No 0.20  1.8257  No 0.20 
Clark 10.90  4  0.0277  Yes  ≥  0.05  0.1479 0.1495  No 0.20  1.0176  No n.a. 
BTA 14.46  4  0.0060  Yes  ≥ 0.01  0.1977 0.0405  No  ≥ 0.05  1.4480  No  0.20 
MASIS-CAII  6.37  4  0.1735  No 0.20  0.1099 0.5831  No n.a. 0.9572  No n.a. 
MCY  5.93  4  0.2048 No  n.a.  0.2003 0.0466 Yes  ≥ 0.05  1.5082  No  0.20 
BKST  0.48  2  0.7855  No n.a. 0.1293 0.7505  No n.a. 0.6314  No n.a. 
CAI  5.55  5  0.1352  No 0.20  0.1643 0.2061  No n.a. 1.7636  No 0.20 
CAII 6.67  3  0.0833  No  ≥  0.10  0.1582 0.2427  No n.a. 1.4951  No 0.20 
CAIV  5.48  4  0.2413  No n.a. 0.1512 0.2898  No n.a. 1.2785  No n.a. 
logCAII-GO  7.01  4  0.1354 No  0.20  0.2197 0.0433 Yes  ≥ 0.01  1.3180  No  n.a. 
logCAIV-GO  0.84  3  0.8395 No  n.a.  0.2010 0.0804 No  ≥ 0.10  1.4905  No  0.20 
Nitro  0.34  3  0.9518  No n.a. 0.0985 0.8083  No n.a. 0.5312  No n.a. 
MGWTI 4.11  3  0.2498  No n.a. 0.1953 0.1206  No 0.20  1.9225  No 0.20 
logCAI-GO  0.43  4  0.9796  No n.a. 0.1051 0.8093  No n.a. 0.2895  No n.a. 
TTKSS-CAII  0.98  2  0.6125  No n.a. 0.1159 0.7891  No n.a. 0.4444  No n.a. 
ERBAT 2.46  5  0.7828  No n.a. 0.1217 0.5086  No n.a. 0.3568  No n.a. 
Stat. = value of the statistics; df = degree of freedom;  
Reject5% = reject the hypothesis at a significance level of 5%;  
Rejectα% = the significance level at which the hypothesis is rejected, whenever appropriate; 
p = p-value; n.a. = not applicable 
 
The maximum likelihood estimation was applied in order to estimate a series of 
population parameters. The obtained results expressed as MLE value, population mean and 
population standard deviation are presented in Table 6. The power of error and expected 
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kurtosis (KuGL) were also investigated according to the Gauss-Laplace distribution (see Table 
6). 
 
Table 5. Results of Gauss-Laplace distribution testing: Chi square (CS), Kolmogorov 
Smirnov (KS) and Anderson Darling (AD) tests 
Chi-square Kolmogorov-Smirnov  Anderson-Darling  Set 
Stat. df p  Reject5% Rejectα% Stat. p  Reject5% Rejectα% Stat. Reject5% Rejectα%
Y209  1.37  7  0.9864  No n.a. 0.0270 0.9971  No n.a. 0.1246  No n.a. 
RRF 17.94  7  0.0123  Yes  ≥0.02 0.0922 0.0537  No  ≥0.1 1.5687  No  ≥0.2 
Y206  11.60  7  0.1144  No 0.2 0.0511 0.6359  No n.a. 0.7665  No n.a. 
Y205  7.65  7  0.3642  No n.a. 0.0444 0.7976  No n.a. 0.4958  No n.a. 
C166  2.98  7  0.8864  No n.a. 0.0525 0.7286  No n.a. 0.5541  No n.a. 
OrgPest  7.37  7  0.3913  No n.a. 0.0874 0.2116  No n.a. 1.6051  No 0.2 
Anthra 35.32  6  3.74·10
-6 Yes  ≥0.01 0.1779 5.87E-4 Yes  ≥0.01 5.0393  Yes  ≥0.01 
Anthra-GO 28.45  6  7.74·10
-5 Yes  ≥0.01 0.1528 0.0054  Yes  ≥0.01 3.7083  Yes  ≥0.02 
MPC  8.83  6  0.1835  No 0.2 0.0499 0.9321  No n.a. 0.2458  No n.a. 
MDL  1.37  7  0.9864  No n.a. 0.0230 0.9971  No n.a. 0.1246  No n.a. 
Diamino 8.42  6  0.2091  No n.a. 0.1338 0.0778  No ≥0.10 1.4811  No  0.2 
Diamino-GO  8.21  6  0.2228  No n.a. 0.1178 0.1652  No 0.2 1.1734  No n.a. 
lnCHF  2.08  6  0.9124  No n.a. 0.0509 0.9695  No n.a. 0.2982  No n.a. 
AAT  8.05  5  0.1534  No 0.2 0.1071 0.3804  No n.a. 0.9035  No n.a. 
DZGALYL  6.97  5  0.2231  No n.a. 0.0816 0.7652  No n.a. 0.425  No n.a. 
IMHH 11.86  4  0.0184  Yes  ≥0.02  0.1416 0.1451  No 0.2 1.1271  No n.a. 
InHIV  4.71  4  0.3179  No n.a. 0.1368 0.2157  No n.a. 1.0520  No n.a. 
InACE  3.13  5  0.6798  No n.a. 0.1572 0.1021  No 0.2 1.8734  No 0.2 
Clark 11.37  4  0.0227  Yes  ≥0.05  0.1498 0.1398  No 0.2 1.0195  No n.a. 
BTA 14.46  4  0.0060  Yes  ≥0.01 0.1953 0.0444  Yes  ≥0.05 1.4305  No  0.2 
MASIS-CAII  4.52  4  0.3406  No n.a. 0.0838 0.8690  No n.a. 0.5835  No n.a. 
MCY 4.52  4  0.3407  No  n.a.  0.1845 0.0819  No  ≥0.10 1.300  No  n.a. 
ERBAT 1.28  5  0.9373  No n.a. 0.1194 0.5325  No n.a. 0.3477  No n.a. 
CAI  2.77  4  0.5967  No n.a. 0.1110 0.6667  No n.a. 0.6642  No n.a. 
CAII  2.24  5  0.8149  No n.a. 0.1536 0.2731  No n.a. 0.7541  No n.a. 
CAIV  3.81  4  0.4319  No n.a. 0.1284 0.4850  No n.a. 1.0265  No n.a. 
Nitro  0.59  3  0.8989  No n.a. 0.1010 0.7845  No n.a. 0.5278  No n.a. 
logCAII-GO 6.91 4 0.1406  No  0.2  0.2303 0.0296 Yes  ≥0.05 1.3749  No  0.2 
logCAIV-GO 8.75  4  0.0676  No  ≥0.10 0.2090 0.0620  No  ≥0.10 1.3723  No  n.a. 
MGWTI 3.86  3  0.2771  No n.a. 0.1739 0.2140  No n.a. 1.8354  No 0.2 
logCAI-GO  0.42  3  0.9371  No n.a. 0.1130 0.7361  No n.a. 0.3097  No n.a. 
TTKSS-CAII  0.12  3  0.9887  No n.a. 0.0890 0.9601  No n.a. 0.3719  No n.a. 
BKST  0.56  2  0.7561  No n.a. 0.1319 0.7290  No n.a. 0.6084  No n.a. 
Stat. = value of the statistics; df = degree of freedom; Reject5% = reject the hypothesis at a significance level of 5%;  
Rejectα% = the significance level at which the hypothesis is rejected, whenever appropriate; p = p-value; n.a. = not applicable 
 
The analysis of the distance between the sample and the population (expected) mean 
and between the sample and the population standard deviation revealed the following (see 
Table 6, Figure 1):  
  The mean of most investigated sets was likely to be Gauss-Laplace. 
  The standard deviation of most investigated sets of compound was likely to be Gauss. 
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Table 6. Results of MLE analysis 
Laplace (p=1)  Gauss (p=2)  Gauss-Laplace  Set G.O. 
MLE µ  σ MLE  µ  σ MLE  µ  σ p  KuGL
Y209  No  71.55    0.606  0.205 89.27 0.599 0.180 89.85 0.598  0.180  2.331  2.732
RRF  No -116.37    0.722  0.383 -112.97 0.769 0.352 -111.19 0.746  0.353  1.552  3.648
Y206  Yes  -378.84    6.514  0.931 -365.87 6.481 0.829 -365.32 6.479  0.828  1.791  3.245
Y205  No -371.62    6.511  0.914 -354.21 6.465 0.801 -354.21 6.465  0.801  2.010  2.990
C166  No  -489.39   -0.261  2.008  -480.78  -0.348 1.802 -480.65  -0.325  1.802  1.846  3.173
OrgPest  No -272.75    2.400  0.976 -271.92 2.518 0.904 -269.83 2.443  0.906  1.443  3.901
Anthra  Yes  -188.80    4.560  0.735 -211.20 4.740 0.773 -186.89 4.560  0.787  0.784  8.883
Anthra-GO No  -171.53    4.560  0.679 -187.79 4.695 0.691 -171.04  4.560  0.702  0.879  7.296
MPC  No -236.94    1.960  1.142 -228.42 1.903 1.007 -228.39 1.900  1.007  2.083  2.922
MDL  No -176.34    -0.049 0.833 -173.75 -0.094 0.762 -173.47 -0.063 0.764 1.635  3.488
Diamino  Yes -94.06    4.959  0.546 -96.56 4.841 0.518 -93.87 4.914  0.519  1.302  4.330
Diamino-GO No  -87.34    4.959  0.521 -87.40  4.86 0.485 -86.35 4.907  0.487  1.458 3.863
lnCHF  No -208.09    3.190  1.365 -199.63 3.224 1.187 -199.17 3.206  1.187  2.468  2.649
AAT  No -119.01    4.180  0.860 -113.34 4.254 0.755 -112.98 4.316  0.757  2.595  2.582
DZGALYL  No  -96.32    0.669  0.751 -92.60 0.744 0.670 -92.44 0.768  0.672  2.489  2.637
IMHH  No -109.06    -0.082 0.864 -106.94 -0.158 0.785 -106.08 -0.306 0.800 3.851  2.213
InHIV  No -155.61    7.010  1.726 -149.45 6.542 1.489 -146.27 6.337  1.465  3.500  2.282
InACE  No -120.63    2.788  1.100 -118.13 3.051 0.993 -117.98 2.989  0.993  1.724  3.341
Clark  No  -97.59    -0.074 0.852 -96.18 -0.138 0.779 -96.16 -0.228 0.786 2.775  2.502
BTA  No  -66.72    1.737  0.682 -65.47 1.983 0.622 -64.54 2.149  0.634  4.000  2.188
MASIS-CAII No  -56.91    1.826  0.602 -49.87 1.749 0.505 -44.75 1.749  0.510  4.000  2.188
MCY  No  -66.51    0.0008 0.732 -69.54 0.0004 0.706 -66.51 0.0006 0.732  1.000  6.000
BKST  No  -96.36    8.500  1.230 -94.88 8.457 1.117 -94.79 8.485  1.117  1.749  3.304
CAI Yes  -35.90    0.845  0.485 -45.16 0.849 0.529 -35.03 0.845  0.528  0.746  9.749
CAII Yes  -35.83  0.477  0.484 -43.50 0.474 0.514 -32.76 0.477  0.573  0.588  16.361
CAIV Yes
  -35.87 0.750  0.484 -45.19 0.743 0.529 -33.16 0.701  0.570  0.587  16.430
logCAIV-GO No  -21.45    0.699  0.385 -25.02 0.657 0.382 -21.11 0.699  0.396  0.885  7.217
logCAII-GO  No  -13.62    0.477  0.338 -14.25 0.442 0.318 -14.09 0.472  0.319  1.620  3.515
Nitro  No -100.78    6.524  1.560 -96.98 6.496 1.356 -96.95 6.485  1.356  2.150  2.864
MGWTI  No  -84.13    -1.200 1.374 -82.01 -0.692 1.228 -79.96 -0.692 1.246 3.999  2.189
logCAI-GO No  -4.12  0.845  0.283 -1.661 0.846 0.250 -1.61 0.844  0.250  2.259  2.781
TTKSS-CAII No  -77.55    7.530  1.660 -72.97 7.444 1.384 -71.16 7.258  1.365  3.774  2.227
ERBAT  No  -65.36    0.531  1.593 -62.19 0.379 1.357 -60.14 0.379  1.385  3.999  2.189
G.O. = Grubbs outliers at significance level of 5%; MLE = Maximum Likelihood Estimation;  
µ = population mean; σ = population standard error;  
KuGL = expected kurtosis under Gauss-Laplace assumption 
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Figure 1. Absolute frequency of the minimum difference between population and sample 
mean and between population and sample standard deviation (right graph: absolute 
difference) 
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  According to the difference between the population and the sample mean, the following 
sets of compounds had an activity/property mean that was: 
a) Slightly higher than the expected Laplace mean: logCAI-GO, CAI, lnCHF, RRF, AAT, 
DZGALYL, OrgPest, Anthra-GO, logCAII-GO, Anthra, BTA, InACE, MGWTI. 
b) Slightly higher than the expected Gauss mean: logCAII-GO, Diamino-GO, CAII, 
Anthra, OrgPest, CAI, Diamino, RRF, Y205, AAT, ERBAT, CAIV, MGWTI, Anthra-
GO, C166, TTKSS-CAII, Nitro. 
c) Slightly higher than the expected Gauss-Laplace mean: InHIV, TTKSS-CAII, logCAII-
GO, Anthra, IMHH, Anthra-GO, Clark, OrgPest, InACE, CAIV, RRF, lnCHF, Nitro, 
CAI, MPC, logCAI-GO, Y206, Y209, Y205, ERBAT. 
  According to the difference between the population and the sample standard deviation, the 
following sets of compounds proved to present errors in each individual measurement (the 
sample standard deviation was higher than the population (expected) MLE standard 
deviation) in terms of:  
a)  Laplace (p = 1): CAIV, CAI, logCAII-GO, Anthra, CAII, and Anthra-GO. 
b)  Gauss (p = 2): all investigated sets. 
c)  Gauss-Laplace: logCAII-GO, TTKSS-CAII, InHIV, Nitro, BKST, InACE, CAI, 
lnCHF, MPC, C166, logCAI-GO, AAT, DZGALYL, Y206, Y205, MDL, 
Diamino, Diamino-GO, OrgPest, Y209, MASIS-CAII, Clark, and ERBAT. 
Laplace obtained a higher number of agreements in terms of the minimum difference 
between population and sample mean as well as between population and sample standard 
deviation (23 sets when the difference was investigated, 33 sets when the absolute difference 
was investigated). The descending classification of the difference obtained was Laplace – 
Gauss-Laplace – Gauss and of the absolute difference obtained was Laplace – Gauss – Gauss-
Laplace. 
The analysis of the power of error (p) calculated by applying the MLE (Gauss-Laplace) 
revealed the following: 
  Values below 1 were obtained for the following sets: CAIV, CAII, CAI, Anthra, Anthra-
GO, logCAIV-GO. In all these sets of compounds the activity referred to the compound 
concentration required for 50% growth inhibition. IC50 depends on several of factors: 
concentration of target molecule, concentration of inhibitor, substrate, and other 
experimental conditions [65, 66]. 
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  The MCY set was the only set for which an integer number (of 1) was obtained. This set 
was small, with a sample size of 45 compounds, and did not present any ties. The blood 
(Cblood) and brain (Cbrain) concentrations, measured in mmol/L with variations in net 
charge at pH = 7.4 [67] ranged from -2.00 to 1.04.  
  Values higher than 1 and smaller than 2 were obtained for the following sets: Diamino, 
Diamino-GO, OrgPest, RRF, logCAII-GO, MDL, InACE, BKST, Y206, and C166. Some 
sets referred to the compound concentrations required for 50% growth inhibition 
(Diamino, Diamino-GO, logCAII-GO, and InACE), which are subject to different 
instrumental and human errors. The MDL set comprises a series of compounds collected 
from different previously reported research. The absence of the same experimental 
protocol could lead to the obtained results (the blood brain barrier was the observed 
activity with experimental values ranging from -2.00 to 1.44, very close to the MCY but 
on a sample of 105 compounds). Other sets from this class referred to the IC50 activity: 
Diamino, Diamino-GO, logCAII-GO, InACE. The OrgPest set had the soil sorption 
coefficient of pesticide that measured the chemicals’ propensity to adsorb soil particles. 
The determination of this coefficient depends on a variety of operational difficulties and 
experimental artifacts related to the separation of phases, agitation speed, time for 
equilibration, exposure of new separation phases during agitation, speed of sorption [68]. 
The response factor was the property investigated for the RRF set. The response factor 
comprised the area of the target analyte and corresponding internal standard and by their 
concentrations (subject to instrumental errors and the researcher’s skills). The protonation 
constant (BKST) and partition coefficient (Y206) belong to the same class of 
experimental determinations. The thermodynamic solubility of C166 also belongs to this 
class and it depends on a series of factors (phase, physical properties of solute, 
temperature, pressure, etc) that could, together with the human factor, influence 
experimental determinations [69]. 
  A value almost equal with 2 was obtained for the octanol-water partition coefficient after 
removal of the identified outlier [12] (Y205). 
  A value higher than 2 was observed for the following sets: MPC (Molecular partition 
coefficient in n-octanol / water system), Nitro (Toxicity (logLD50), logCAI-GO 
(Carbonic anhydrase I inhibitory activity (logIC50), Y209 (Chromatographic retention 
times), lnCHF (Concentration high food), DZGALYL (Concentration high food), AAT 
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(Acute aquatic toxicity), Clark (Brain-blood partition coefficient), InHIV (HIV1 inhibition 
(log(106/C50), TTKSS-CAII (Carbonic anhydrase II inhibitory activity), IMHH (Brain-
blood partition coefficient), MGWTI (Cell growth inhibitory activity (log(1/IC50)), 
ERBAT (Estrogen receptor binding affinity), BTA (Bitter tasting activity), and MASIS-
CAII (Carbonic anhydrase II inhibitory activity). The value higher than 2 could be 
explained by the existence of absolute measurement errors. All these sets must be rejected 
if a MLR (Multiple-Linear regression) analysis on qSAR (quantitative Structure-Activity 
Relationships) models is conducted. 
  The bitter tasting activity (BTA), a purely subjective activity, proved to have a value of 4. 
Due to the nature of the observed activity, BTA was expected to have a power of error 
higher than 2 (Gauss). 
The removal of the identified outliers classified the sets of compounds into a higher 
power of error class as compared with the entire compounds from a data set (an exception 
from this rule was observed in the logCAIV-GO set). Since this behaviour was only observed 
in the CAIV set (not in the CAI and CAII sets that belong to the same researchers and are 
subject to the same errors) it could be concluded that this is related to the carbonic anhydrase 
IV inhibitory activity. 
The kurtosis analysis was performed in terms of distances between the expected 
population kurtosis (according to the Laplace, Gauss, and Laplace-Gauss assumptions) and 
the sample kurtosis. The trend evolution showed that the distances according to Gauss and to 
Laplace followed a similar pattern while the Gauss-Laplace pattern was chaotic (Figure 2). 
Five sets of investigated compounds proved to be close to the expected Laplace population 
kurtosis (Anthra, Anthra-GO, CAI, CAII, and CAIV sets). Eleven sets of compounds proved 
to be closest to the expected Gauss population kurtosis (AAT, BKST, BTA, Clark, IMHH, 
logCAII-GO, MCY, MDL, MPC, Nitro, and Y205). In most cases, the sample kurtosis proved 
to be closest to the expected Gauss-Laplace population kurtosis. A significant negative 
correlation between the minimum distance of the expected Laplace population kurtosis and 
the sample kurtosis with p (determined by MLE) was obtained by Spearman’s rank 
correlation coefficient (ρ = -0.621, p = 1.1·10-4). The sample kurtosis proved to highly 
correlate with the expected Gauss-Laplace population kurtosis (ρ = 0.908, p = 1.1·10-6; 
Cronbach's Alpha coefficient = 0.712) as identified above. 
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Figure 2. Trends of distance from the expected population kurtosis (Gauss, Laplace and 
Gauss-Laplace assumptions) 
 
 
Conclusions 
 
The maximum likelihood approach was applied in order to classify experimental data 
of active biological compounds. A series of population parameters were estimated according 
to the Laplace, Gauss and Gauss-Laplace assumptions. The mean of most investigated sets 
was likely to be Gauss-Laplace while the standard deviation of most investigated sets of 
compound was likely to be Gauss. The MLE analysis allowed making assumptions regarding 
the type of errors in the investigated sets. The kurtosis analysis revealed that most 
investigated sets of compounds were closer to Gauss-Laplace general distribution than 
expected normal (Gauss) distribution and were not suitable for multiple linear regression 
analyses. 
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